Disclosures for "Valbenazine Decreases Disease Burden in Patients with Chorea Associated with Huntington Disease: Patient-Reported Huntington Disease Health Index (HD-HI) Results From the KINECT-HD Trial ")
-
Dr. Heatwole has received personal compensation for serving as an employee of Legal Med. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Virginia Commonwealth University. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IRIS. Dr. Heatwole has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Recursion. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avidity. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pennsylvania Prop and Gas Ins. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Harmony. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for cytokinetics. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for scholar rock. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for neurocrine. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving as a Consultant for swan bio. Dr. Heatwole has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Dr. Heatwole has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Med. The institution of Dr. Heatwole has received research support from NIH. The institution of Dr. Heatwole has received research support from Recursion. The institution of Dr. Heatwole has received research support from MDA. The institution of Dr. Heatwole has received research support from PPMD. The institution of Dr. Heatwole has received research support from FARA. The institution of Dr. Heatwole has received research support from Curesma. The institution of Dr. Heatwole has received research support from ALSA. The institution of Dr. Heatwole has received research support from Huntington Study Group. The institution of Dr. Heatwole has received research support from department of defence. The institution of Dr. Heatwole has received research support from swan bio. The institution of Dr. Heatwole has received research support from Parent project. Dr. Heatwole has received intellectual property interests from a discovery or technology relating to health care.
-
Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Michael J. Fox Foundation. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Pharmaceuticals. Dr. Furr-Stimming has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. The institution of Dr. Furr-Stimming has received research support from Cures within Reach. The institution of Dr. Furr-Stimming has received research support from Huntington's Disease Society of America. The institution of Dr. Furr-Stimming has received research support from Roche/Genetech. The institution of Dr. Furr-Stimming has received research support from Uniqure. The institution of Dr. Furr-Stimming has received research support from CHDI. The institution of Dr. Furr-Stimming has received research support from Vaccinex. The institution of Dr. Furr-Stimming has received research support from Huntington Study Group/Neurocrine. The institution of Dr. Furr-Stimming has received research support from NIH/University of Iowa. Dr. Furr-Stimming has received publishing royalties from a publication relating to health care.
-
Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Spark . The institution of Dr. Claassen has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alterity. Dr. Claassen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva Neuroscience. Dr. Claassen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for HD Insights. The institution of Dr. Claassen has received research support from NIH. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from HDSA. The institution of Dr. Claassen has received research support from Department of Defense. The institution of Dr. Claassen has received research support from Griffin Family Foundation. The institution of Dr. Claassen has received research support from Neurocrine. The institution of Dr. Claassen has received research support from Vaccinex. The institution of Dr. Claassen has received research support from AbbVie. The institution of Dr. Claassen has received research support from CHDI. The institution of Dr. Claassen has received research support from Genentech/ Roche. The institution of Dr. Claassen has received research support from Prilenia. The institution of Dr. Claassen has received research support from Neurocrine/ HSG.
-
Elise Kayson has nothing to disclose.
-
Ms. Goldstein has nothing to disclose.
-
Dr. Klepitskaya has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc.
-
Dr. Liang has received personal compensation for serving as an employee of Neurocrine Biosciences. Dr. Liang has stock in Neurocrine Biosciences.
-
Dr. Haubenberger has received personal compensation for serving as an employee of Neurocrine Biosciences, Inc. Dr. Haubenberger has stock in Neurocrine Biosciences. Dr. Haubenberger has a non-compensated relationship as a Member of the Board with American Society for Experimental Neurotherapeutics that is relevant to AAN interests or activities.